Avanos Medical finalizes separation with Officer Greiner; $2.1M severance, accelerated RSUs

AVANOS MEDICAL, INC.

Cash severance of $2.1M plus prorated 2025 bonus based on actual performance, paid in 2026.
Immediate vesting of 44,189 TRSUs granted Oct 29, 2024 and 10,000 TRSUs granted Dec 3, 2024.
Consulting engagement as independent contractor through May 16, 2025 with $50,000 fee.
COBRA premium coverage for six months at 100% of monthly premiums.
Separation conditioned on non-revocation of release and compliance with confidentiality agreement.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael C. Greiner

Other Named Officer

AVNS · AVANOS MEDICAL, INC.

Filed: April 30, 2025, 7:59 PM ET

On April 28, 2025, Avanos Medical, Inc. (the “Company”) and Michael C. Greiner entered into a Separation and Consulting Agreement (the “Separation and Consulting Agreement”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael C. Greiner departed as other_named_officer at AVANOS MEDICAL, INC..

Action: departed

Exact text from the filing

On April 28, 2025, Avanos Medical, Inc. (the “Company”) and Michael C. Greiner entered into a Separation and Consulting Agreement (the “Separation and Consulting Agreement”).

View on SEC.gov

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-25-000085

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.